Many studies have shown that production of colicin V is not necessary for pathogenicity of E. coli by itself but it is a marker for other properties associated with the presence of ColV plasmid [61].
As cell proliferation in the immune system is only a surrogate marker for functional properties, we next analyzed the cytotoxicity of NK cells.
Our results provided evidence that YWHAZ may be an important molecular marker for determining malignant properties and a target for molecular therapy in patients with gastric cancer.
This finding highlights the important role of sucrose metabolism in fiber morphogenesis and as a diagnostic marker for the structural properties that distinguish the superior Pima fiber phenotype.
Although studies of larger cohorts are needed to validate these findings before moving to a clinical setting, our results may provide the possibility that YWHAZ is an important molecular marker for determining malignant properties and targets for molecular therapy in patients with this lethal disease.
In this study, we examined lysyl oxidase (LOX -mediated crossLOX -mediateders for mecrosslinksroperties during embryonic tendon formasion and the potential to detect themarkersestructively.
Among these genes, CD133 and EpCAM are proved to be the most important markers for CSC properties in HCC, ABCG2 is especially overexpressed in SP cells as one of the ABC [ 1].
Fast myosin is a totally specific marker for skeletal muscle, a property not shared by any of the markers currently in use such as CK and myoglobins.
Initial LD was generated by establishing marker properties for the population, simulating underlying, unobservable, linked bi-allelic markers that each have an allele frequency of 0.5, and setting minor allele frequencies for observed markers to <0.5 by randomly replacing a corresponding fraction of the underlying alleles by the major allele.
Therefore, we could use these selected genomic properties as marker for RIDGEs in a defined neighborhood to elucidate positioning of these regions relative to heterochromatin during differentiation and ectopic MeCP2 expression (Fig. 3).
